I would rather prefer that Libigel is alive and well... In the PR they said “We are committed to rebuilding BioSante in order to maximize value for our company and stockholders. Although we are disappointed about the recently reported LibiGel clinical efficacy results, we are optimistic about the future of BioSante,” The word "Rebuilding" shows there is something wrong. Yes, we all know what the problem was, but to new investors that read that and don't do their DD, they will just avoid the stock like the plague...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.